Differences in Time to Disease Progression Do Not Predict for Cancer-specific Survival in Patients Receiving Immediate or Deferred Androgen-deprivation Therapy for Prostate Cancer: Final Results of EORTC Randomized Trial 30891 with 12 Years of Follow-up-Reference-Cited by-同舟云学术

Differences in Time to Disease Progression Do Not Predict for Cancer-specific Survival in Patients Receiving Immediate or Deferred Androgen-deprivation Therapy for Prostate Cancer: Final Results of EORTC Randomized Trial 30891 with 12 Years of Follow-up

Published:2014-11 Issue:5 Volume:66 Page:829-838
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Studer Urs E.,Whelan Peter,Wimpissinger Florian,Casselman Jacques,de Reijke Theo M.,Knönagel Hartmut,Loidl Wolfgang,Isorna Santiago,Sundaram Subramanian K.,Collette Laurence

Publisher

Elsevier BV

Subject

Urology

Reference29 articles.

1. Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891;Studer;J Clin Oncol,2006

2. Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M2 prostate cancer not suitable for local curative treatment (EORTC 30891);Studer;Eur Urol,2008

3. Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter;Thompson;N Engl J Med,2004

4. Effect of dutasteride on the risk of prostate cancer;Andriole;N Engl J Med,2010

5. Bicalutamide (Casodex) 150mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression;Wirth;Urology,2001

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking through resistance in mCRPC: Enzalutamide analogues as effective anticancer agents for enhanced male survival;Results in Chemistry;2023-12

2. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up;Journal of Urology;2022-07

3. Artificial Intelligence-Based Prognostic Model for Urologic Cancers: A SEER-Based Study;Cancers;2022-06-26

4. Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer;Cancers;2022-04-01

5. The curative effect of androgen deprivation therapy alone is insufficient in high-risk prostate cancer;Medicine;2021-08-06